# CCSG - Administrative Supplement-CCITLA - 2021

> **NIH NIH P30** · UNIVERSITY OF CHICAGO · 2021 · $59,999

## Abstract

PROJECT SUMMARY
The Cancer Clinical Investigator Team Leadership Award (CCITLA) recognizes and supports outstanding
clinical investigators who enable their cancer center’s NCI-funded clinical trials enterprise. It is the intent of the
CCITLA to support mid-level clinical investigators at NCI-designated Cancer Centers who actively enroll
patients and participate extensively and collaboratively in NCI-funded clinical trials. This award is intended to
recognize, and support efforts related to interventional trials. The CCITLA is designed to promote the retention
of investigators in academic clinical research careers by providing salary support to individuals who do not
have independent research grant funding as a Principal Investigator.
A candidate for the CCITLA must be nominated by the Cancer Center Director. An ideal candidate will have
played a critical role in the development of NCI-funded clinical trials at the cancer center and have a record of
service on institutional clinical trial committees and in NCI clinical trial-related activities.
Dr. Daniel Catenacci is being nominated for the Cancer Clinical Investigator Team Leadership Award (CCITLA)
based on his significant prior experience in NCI-sponsored clinical trials, his ongoing leadership within the
University of Chicago Medicine Comprehensive Cancer Center (UCCCC) and his career plans detailed herein
to expand patient access and accrual on NCI clinical trials as well as develop a precision-oncology education
program within the UCCCC.
Funding support provided by this award will facilitate the implementation of two main projects:
 1) Building out NCI clinical trial capacity at University of Chicago Medicine Comprehensive Cancer Center
(UCCCC) network affiliate sites; and
 2) Developing a precision-oncology education program within the UCCCC for fellows in medical oncology,
as well as other disciplines in which precision- and immuno-oncology-related medical issues are of relevance.

## Key facts

- **NIH application ID:** 10327140
- **Project number:** 3P30CA014599-46S2
- **Recipient organization:** UNIVERSITY OF CHICAGO
- **Principal Investigator:** KUNLE ODUNSI
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $59,999
- **Award type:** 3
- **Project period:** 1997-09-01 → 2022-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10327140

## Citation

> US National Institutes of Health, RePORTER application 10327140, CCSG - Administrative Supplement-CCITLA - 2021 (3P30CA014599-46S2). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10327140. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*